Camurus Ab Stock Quote 0RD1 - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

101.20

Bid

0.00

Ask

0.00

Volume

3,986

0.00 Day's Range 0.00

101.20 52 Week Range 101.20

Market Cap

2.567B

Previous Close

101.20

Open

Last Trade

492.95839

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

19,153

Shares Outstanding

55,624,000

Dividend Yield

PE Ratio

5.95

Earnings Per Share (EPS)

7.76

Revenue

1.72B

Net Profit

431.44M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.camurus.com

Headquarters

Lund, Swe

Founded

1970

Camurus Ab is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0RD1. The last closing price for Camurus Ab was SEK101.20. Over the last year, Camurus Ab shares have traded in a share price range of SEK 101.20 to SEK 101.20.

Camurus Ab currently has 55,624,000 shares outstanding. The market capitalization of Camurus Ab is SEK2.57 billion. Camurus Ab has a price to earnings ratio (PE ratio) of 5.95.

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly PR Newswire LUND, Sweden, July 17, 2023 Favorable safety...

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly PR Newswire LUND, Sweden, July 17, 2023 Favorable safety...

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder PR Newswire LUND, Sweden, May 24, 2023 Brixadi is the first treatment for opioid use...

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder PR Newswire LUND, Sweden, May 24, 2023 Brixadi is the first treatment for opioid use...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	101.2	101.2	101.2	6962	101.2	DE
4	101.2	101.2	101.2	7694	101.2	DE
12	101.2	101.2	101.2	19153	101.2	DE
26	101.2	101.2	101.2	25071	101.2	DE
52	101.2	101.2	101.2	17535	101.2	DE
156	101.2	101.2	101.2	9575	101.2	DE
260	101.2	101.2	101.2	7257	101.2	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 6.26 (134.46%)	44.34M
LGVNLongeveron Inc	$ 2.94 (73.96%)	57.09M
HUBCHub Cyber Security Ltd	$ 1.9499 (49.99%)	75.07M
SPCBSuperCom Ltd	$ 0.40 (44.93%)	127.56M
ONVOOrganovo Holdings Inc	$ 1.345 (33.16%)	53.78M
MRNSMarinus Pharmaceuticals Inc	$ 1.29 (-82.85%)	35.57M
NXTPNextPlay Technologies Inc	$ 0.20 (-56.52%)	30.41k
CSLRComplete Solaria Inc	$ 0.26 (-50.00%)	814.26k
SWVLSwvl Holdings Corporation	$ 8.10 (-38.96%)	312.72k
MOTSMotus GI Holdings Inc	$ 0.173 (-34.25%)	1.37M
SQQQProShares UltraPro Short QQQ	$ 11.445 (5.10%)	201.03M
SNGXSoligenix Inc	$ 0.4697 (21.65%)	134.5M
SPCBSuperCom Ltd	$ 0.40 (44.93%)	127.56M
NKLANikola Corporation	$ 0.6503 (-7.14%)	121.2M
JAGXJaguar Health Inc	$ 0.109 (20.71%)	115.11M